Lung Transplantation in Patients with Previous or Unknown Oncological Disease: Evaluation of Short- and Long-Term Outcomes
Cancers · 26.01.2024 · 16 (3) · 538
DOI: 10.3390/cancers16030538 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancers, online erschienen am 26.01.2024. Verfasst von Chiara Catelli und 10 weiteren Autor:innen. Beteiligte Einrichtung: Thoracic Surgery Unit, Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padova, 35121 Padova, Italy. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The accurate selection of the recipient is a crucial aspect in the field of lung transplantation (LTX), especially if patients were previously affected by oncological disease. The aim of this bicentric retrospective study was to evaluate short- and long-term outcomes in patients with previous oncological disease or unknown neoplasia found on native lungs submitted to LTX, compared to a control group. A total of 433 patients were included in the analysis, 31 with malignancies (Group 1) and 402 without neoplastic disease (Group 2). The two groups were compared in terms of short- and long-term outcomes. Patients in Group 1 were older (median age 58 years vs. 50 years, p = 0.039) and mostly affected by idiopathic pulmonary fibrosis (55% vs. 40% p = 0.002). Even though in Group 1 a lower rate of late post-operative complications was found (23% vs. 45%, p = 0.018), the median overall survival (OS) was lower compared to the control group (10 months vs. 29 months, p = 0.015). LTX represents a viable therapeutic option for patients with end-stage lung disease and a history of neoplastic disease. However, every case should be carefully debated in a multidisciplinary setting, considering oncological (histology, stage, and proper disease free-interval) and clinical factors (patient’s age and comorbidities). A scrupulous post-transplant follow-up is especially mandatory in those cases.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Thoracic Surgery Unit, Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padova, 35121 Padova, Italy.
- Unit of Biostatistics Epidemiology and Public Health, Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padova, 35121 Padova, Italy.
- Lung Transplant Unit, University of Siena, Azienda Ospedaliero-Universitaria Senese, 53100 Siena, Italy.
- Respiratory Disease and Lung Transplant Unit, University of Siena, Azienda Ospedaliero-Universitaria Senese, 53100 Siena, Italy.
- Department of Thoracic Surgery, University and Hospital Trust-Borgo Trento, 37126 Verona, Italy.
ORCID-Profile: Chiara Catelli, Stefano Silvestrin, Giulia Lorenzoni, David Bennett, Alessio Campisi, Elena Bargagli
Zitieren
APA
Catelli, C., Faccioli, E., Silvestrin, S., Lorenzoni, G., Luzzi, L., Bennett, D., Schiavon, M., Campisi, A., Bargagli, E., Dell'Amore, A., & Rea, F. (2024). Lung Transplantation in Patients with Previous or Unknown Oncological Disease: Evaluation of Short- and Long-Term Outcomes. Cancers, 16(3), 538. https://doi.org/10.3390/cancers16030538
Vancouver
Catelli C, Faccioli E, Silvestrin S, Lorenzoni G, Luzzi L, Bennett D, et al. Lung Transplantation in Patients with Previous or Unknown Oncological Disease: Evaluation of Short- and Long-Term Outcomes. Cancers. 2024;16(3):538. doi:10.3390/cancers16030538
BibTeX
@article{Catelli2024,
author = {Catelli, Chiara and Faccioli, Eleonora and Silvestrin, Stefano and Lorenzoni, Giulia and Luzzi, Luca and Bennett, David and Schiavon, Marco and Campisi, Alessio and Bargagli, Elena and Dell'Amore, Andrea and Rea, Federico},
title = {Lung Transplantation in Patients with Previous or Unknown Oncological Disease: Evaluation of Short- and Long-Term Outcomes},
journal = {Cancers},
year = {2024},
volume = {16},
number = {3},
pages = {538},
doi = {10.3390/cancers16030538}
}
EUVIMED